Trial confirms Ebola vaccine candidate safe, equally immunogenic in Africa
Tuesday, December 23, 2014 - 18:00
in Health & Medicine
Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year. The findings are from the first trial of filovirus vaccines in Africa.